ArticleBMC nephrology2024

Evaluation of urinary volatile organic compounds as a novel metabolomic biomarker to assess chronic kidney disease progression.

Henry H L Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.